Rafferty Asset Management, LLC Illumina, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 93,127 shares of ILMN stock, worth $13.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

93,127

Previous 118,362 21.32%

Holding current value

$13.1 Million

Previous $12.4 Million 1.71%

% of portfolio

0.04%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$105.28 - $135.9 $2.66 Million - $3.43 Million	-25,235 Reduced 21.32%	93,127 $12.1 Million
Q2 2024 Aug 13, 2024	BUY	$101.05 - $133.57 $177,342 - $234,415	1,755 Added 1.51%	118,362 $12.4 Million
Q1 2024 May 13, 2024	BUY	$127.73 - $147.2 $1.54 Million - $1.77 Million	12,046 Added 11.52%	116,607 $16 Million
Q4 2023 Feb 13, 2024	BUY	$92.79 - $142.53 $2.61 Million - $4.02 Million	28,176 Added 36.89%	104,561 $14.6 Million
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $3.18 Million - $4.74 Million	24,653 Added 47.66%	76,385 $10.5 Million
Q2 2023 Aug 11, 2023	BUY	$183.43 - $232.67 $2.18 Million - $2.76 Million	11,879 Added 29.81%	51,732 $9.7 Million
Q1 2023 May 11, 2023	BUY	$193.75 - $232.55 $445,431 - $534,632	2,299 Added 6.12%	39,853 $9.27 Million
Q4 2022 Feb 13, 2023	SELL	$187.24 - $242.74 $1.29 Million - $1.67 Million	-6,892 Reduced 15.51%	37,554 $7.59 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $1.09 Million - $1.4 Million	6,169 Added 16.12%	44,446 $8.48 Million
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $2.37 Million - $4.81 Million	13,062 Added 51.8%	38,277 $7.06 Million
Q1 2022 May 13, 2022	BUY	$303.87 - $423.8 $2.81 Million - $3.92 Million	9,257 Added 58.01%	25,215 $8.81 Million
Q4 2021 Feb 10, 2022	BUY	$347.28 - $421.83 $645,246 - $783,760	1,858 Added 13.18%	15,958 $6.07 Million
Q3 2021 Nov 10, 2021	BUY	$405.61 - $524.84 $1.24 Million - $1.6 Million	3,057 Added 27.68%	14,100 $5.72 Million
Q2 2021 Aug 10, 2021	SELL	$372.84 - $481.5 $155,474 - $200,785	-417 Reduced 3.64%	11,043 $5.23 Million
Q1 2021 May 10, 2021	SELL	$361.28 - $504.76 $473,276 - $661,235	-1,310 Reduced 10.26%	11,460 $4.4 Million
Q4 2020 Feb 10, 2021	BUY	$292.7 - $370.96 $137,861 - $174,722	471 Added 3.83%	12,770 $4.73 Million
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $19,064 - $28,452	71 Added 0.58%	12,299 $3.8 Million
Q2 2020 Aug 07, 2020	BUY	$256.46 - $373.01 $986,858 - $1.44 Million	3,848 Added 45.92%	12,228 $4.53 Million
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $613,374 - $983,773	-2,932 Reduced 25.92%	8,380 $2.29 Million
Q4 2019 Feb 10, 2020	BUY	$288.29 - $335.49 $1.2 Million - $1.4 Million	4,179 Added 58.59%	11,312 $3.75 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $171,844 - $243,580	644 Added 9.92%	7,133 $2.17 Million
Q2 2019 Aug 09, 2019	SELL	$300.59 - $368.15 $91,078 - $111,549	-303 Reduced 4.46%	6,489 $2.39 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $383,778 - $452,221	1,408 Added 26.15%	6,792 $2.11 Million
Q4 2018 Feb 11, 2019	SELL	$272.46 - $366.54 $674,883 - $907,919	-2,477 Reduced 31.51%	5,384 $1.62 Million
Q3 2018 Nov 09, 2018	BUY	$279.04 - $367.06 $546,639 - $719,070	1,959 Added 33.19%	7,861 $2.89 Million
Q2 2018 Aug 14, 2018	SELL	$228.17 - $292.07 $111,118 - $142,238	-487 Reduced 7.62%	5,902 $1.65 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $86,330 - $104,610	-412 Reduced 6.06%	6,389 $1.51 Million
Q4 2017 Feb 14, 2018	SELL	$202.23 - $230.03 $124,978 - $142,158	-618 Reduced 8.33%	6,801 $1.49 Million
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $1.28 Million - $1.59 Million	7,419	7,419 $1.48 Million

Others Institutions Holding ILMN

# of Institutions

899

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Illumina, Inc. Transaction History